Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q3 2022 Earnings Call Transcript
Operator: Good afternoon, everyone. Thank you for standing by, and welcome to the Atara Biotherapeutics Third Quarter 2022 Financial Results Conference Call.
Atara Biotherapeutics Inc. (ATRA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Maverick Capital Lee Ainslie | 6,290,713 | $18,243,068 | -1% | 0.46% |
| 2. | Redmile Group Jeremy Green | 5,612,056 | $16,274,962 | -11% | 0.7% |
| 3. | D E Shaw D. E. Shaw | 4,229,807 | $12,266,440 | +20% | 0.01% |
| 4. | Citadel Investment Group Ken Griffin | 2,251,718 | $6,529,983 | +62% | 0% |
| 5. | Antipodean Advisors Eric Chen | 1,000,000 | $2,900,000 | 17.94% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.58 | 28,833 | Officer | 125,882 | 2021-06-14 | Filing | |
| $14.48 | 3,500 | Officer | 97,049 | 2021-06-14 | Filing | |
| $14.50 | 2,021 | Officer | 93,549 | 2021-06-11 | Filing | |
| $19.50 | 2,000 | Director | 16,000 | 2019-06-27 | Filing | |
| $11.00 | 9,090 | Director | 9,090 | 2014-10-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.04 | 985 | 270,945 | 2023-05-16 | Filing | ||
| $2.04 | 7,404 | 271,930 | 2023-05-16 | Filing | ||
| $2.04 | 29,766 | 720,962 | 2023-05-16 | Filing | ||
| $2.04 | 19,040 | 276,010 | 2023-05-16 | Filing | ||
| $2.04 | 1,719 | 226,142 | 2023-05-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 9,271,298 | $26,886,765 | 0% | |
| 2. | 8,354,321 | $24,227,531 | 0.15% | |
| 3. | 8,237,473 | $23,888,672 | 0% | |
| 4. | 7,655,769 | $22,201,000 | 0.01% | |
| 5. | 6,855,186 | $19,880,040 | 0% |
News See All
10 Best Stocks to Buy Under $20 According to Jeremy Green's Redmile Group
In this piece, we will take a look at the ten best stocks to buy under $20 according to Jeremy Green's Redmile Group.
5 Healthcare Stocks to Buy According to Lee Ainslie's Maverick Capital
In this piece, we will take a look at the 5 healthcare stocks to buy according to Lee Ainslie's Maverick Capital. If you want to learn more about Mr.
10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green's Redmile Group
In this article, we discuss the 10 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Hedge Fund Sentiment Is Stagnant On Atara Biotherapeutics Inc (ATRA)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
10 Cheap Value Stocks To Buy According To Seth Klarman
In this article, we discuss the cheap value stocks to buy according to Seth Klarman.
5 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will discuss 5 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Is Atara Biotherapeutics Inc (ATRA) A Good Stock To Buy?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Hedge Fund and Insider Trading News: Dan Kamensky, Bill Ackman, Alan Howard, Paul Tudor Jones, Kyle Bass, Vail Resorts, Inc. (MTN), Corcept Therapeutics Incorporated (CORT), and More
On a summer Friday afternoon last year, hedge-fund manager Dan Kamensky broke bankruptcy laws. That evening on a recorded line, he pleaded with a banker to say the whole thing was a misunderstanding.
Is ATRA Stock A Buy or Sell?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.
Billionaire Hedge Funds
